Lijuan Ding
Impact in
-
- Viral-associated cancers and disorders
- CAR-T cell therapy research
-
- MicroRNA in disease regulation
Papers in
-
- DNA Repair Mechanisms 2
- Oncology 8
- CAR-T cell therapy research 3
- Cancer Diagnosis and Treatment 2
- Co-authors
- Shudong Wang (2 shared papers)Yang Zheng (1 shared paper)Honglei Ji (1 shared paper)Quan Liu (1 shared paper)Zheng Xu (1 shared paper)Lihua Dong (5 shared papers)He Huang (5 shared papers)Qiang Wang (2 shared papers)
In The Last Decade
Lijuan Ding
35 papers receiving 533 citations
Peers
Comparison fields: 5 of 84
- Oncology 134
- Cancer Research 63
- Genetics 40
- Immunology 71
- Pathology and Forensic Medicine 48
Countries citing papers authored by Lijuan Ding
This map shows the geographic impact of Lijuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Ding more than expected).
Fields of papers citing papers by Lijuan Ding
This network shows the impact of papers produced by Lijuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Ding. The network helps show where Lijuan Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Lijuan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 88 | |
| 2 | 2015 | 51 | |
| 3 | 2022 | 47 | |
| 4 | 2016 | 34 | |
| 5 | 2015 | 25 | |
| 6 | 2023 | 24 | |
| 7 | 2016 | 24 | |
| 8 | 2022 | 24 | |
| 9 | 2019 | 22 | |
| 10 | 2020 | 20 | |
| 11 | 2022 | 19 | |
| 12 | 2024 | 18 | |
| 13 | 2021 | 18 | |
| 14 | 2016 | 16 | |
| 15 | 2020 | 16 | |
| 16 | 2015 | 12 | |
| 17 | 2014 | 9 | |
| 18 | 2024 | 8 | |
| 19 | 2023 | 8 | |
| 20 | 2019 | 7 |
About Lijuan Ding
Lijuan Ding is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 36 papers that have together received 537 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), MicroRNA in disease regulation (3 papers), DNA Repair Mechanisms (2 papers), Cancer Diagnosis and Treatment (2 papers), Immune cells in cancer (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (134 citations), Cancer Research (63 citations), Genetics (40 citations), Immunology (71 citations) and Pathology and Forensic Medicine (48 citations). Lijuan Ding has collaborated with scholars based in China and Germany. Frequent co-authors include Shudong Wang, Yang Zheng, Honglei Ji, Quan Liu, Zheng Xu, Lihua Dong, He Huang, Qiang Wang, Min Liu and Shudong Wang. Their work appears in journals such as Cell Death Discovery, Oncotarget, Medicine, Frontiers in Oncology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.